{
  "title": "M21-1, Part V, Subpart iii, Chapter 4, Section B - Tuberculosis",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180881/M21-1-Part-V-Subpart-iii-Chapter-4-Section-B-Tuberculosis",
  "content": "<--\nPrevious Section\nNext Section\n-->\nOverview\nIn This Section\nThis section contains the following topics:\nTopic\nTopic Name\n1\nGeneral Information on Tuberculosis\n2\nArrested Tuberculosis\n3\nExhibit: Examples of Ratings for Arrested Tuberculosis\n1\n.\nGeneral Information on Tuberculosis\nIntroduction\nThis topic contains general information about tuberculosis, including\ntuberculosis classification standards\nconsidering infection caused by other mycobacteria\ndiagnosing infection caused by other mycobacteria\nclassifying disease caused by other mycobacteria\nconsidering chest x-rays under 38 CFR 3.370 and 38 CFR 3.371\nreferrals for x-ray interpretation under 38 CF. 3.370 and 38 CFR 3.371\n, and\nprocessing claims based on tuberculin reaction\n.\nChange Date\nApril 15, 2015\nV.iii.4.B.1.a\n.\nTuberculosis Classification Standards\nThe following classification standards were adopted by the American Lung Association under\nThe\nDiagnostic Standards and Classification of Tuberculosis in Adults and Children\n,\n1999:\nAn individual is classified as\nTuberculosis Suspect\nuntil diagnostic procedures are complete.  (\nNote\n:  Do not use the classification\nTuberculosis Suspect\nfor more than three months.)\nDisease caused by other mycobacteria is classified as\nOther Mycobacterial Diseases\n.  (\nNote\n:  Disease caused by other mycobacteria is indistinguishable clinically, radiologically, and histologically from mycobacterium (M.) tuberculosis.)\nReference\n:  For more information on the classification standards, see\nThe\nDiagnostic Standards and Classification of Tuberculosis in Adults and Children\n,\n1999\n.\nV.iii.4.B.1.b\n.\nConsidering Infection Caused by Other Mycobacteria\nOther mycobacteria that may commonly be involved as pathogens are\nM. kansasii\nM. intracellulare, and\nM. scrofulaceum.\nNote\n:  M. bovis is\nrarely responsible for disease where there is effective control of tuberculosis in cattle and pasteurization of milk and milk products, and\nindistinguishable from M. tuberculosis except by culture.\nV.iii.4.B.1.c\n.\nDiagnosing Infection Caused by Other Mycobacteria\nA definitive diagnosis for infection caused by other mycobacteria requires\nevidence of disease (such as an infiltrate visible on a chest x-ray)\nno other cause established by careful clinical and laboratory studies, and\neither\nappearance of the same strain of mycobacteria repeatedly, or\nisolation of the mycobacteria from a closed lesion from which the specimen has been collected and handled under sterile conditions.\nNote\n:  Diagnosis of other mycobacterial infection by skin test is not possible.  The current antigens for mycobacteria other than M. tuberculosis have high cross-reactivity and low specificity.\nV.iii.4.B.1.d\n.\nClassifying Disease Caused by Other Mycobacteria\nWith certain modifications, the classification for tuberculosis is adaptable for classifying other mycobacterial diseases.\nWhen classifying mycobacterial diseases, do\nnot\nuse the following three categories used for tuberculosis\n“\nno exposure, not infected\n”\n“\nexposure, no evidence of infection\n,” or\n“\ninfection, without disease\n.”\nV.iii.4.B.1.e\n.\nConsidering Chest X-Rays Under 38 CFR 3.370 and 38 CFR 3.371\nIf active pulmonary tuberculosis is claimed to be service-connected (SC) and entitlement is not established by other evidence, then consider the x-ray evidence in accordance with\n38 CFR 3.370\nand\n38 CFR 3.371\n.\nReports of x-ray interpretations\nmust\nbe adequate for rating purposes.\nUse the table below to determine which x-ray films are required to prove service connection (SC).\nTo prove ...\nFilms required are ...\ndirect SC\nall service films.\npresumptive SC\ndischarge film (or a service film used for this) and an adequate number of post-service films.\nV.iii.4.B.1.f\n.\nReferrals for X-Ray Interpretation Under 38 CFR 3.370 and 38 CFR 3.371\nOnly designees of the Under Secretary for Health are authorized to interpret x-ray films under\n38 CFR 3.370\nand\n38 CFR 3.371\n.  Refer requests for interpretations to the Department of Veterans Affairs (VA) medical facility for the local regional office (RO).\nNote\n:  If the local VA medical facility is not authorized to make such interpretations, the Director will keep the RO informed of the current location of the designated interpreter for the RO area.  In such a case, refer requests directly to the clinic, center, or hospital.\nV.iii.4.B.1.g\n.\nProcessing Claims Based on Tuberculin Reaction\nReference\n:  For more information on claims based on positive tuberculin reaction, see\nM21-1, Part VIII, Subpart iii, 2.A.1\n.\n2\n.\nArrested Tuberculosis\nIntroduction\nThis topic contains information about arrested tuberculosis, including\nprocessing\ngraduated ratings in effect on August 19, 1968\n, and\nratings in effect after August 19, 1968\nrequesting examinations during the graduated rating period\n, and\nprocessing\nnotification of failure to follow treatment or submit to examination\n, and\ncases of irregular discharge\n.\nChange Date\nAugust 3, 2011\nV.iii.4.B.2.a\n.\nProcessing Graduated Ratings in Effect on August 19, 1968\nFor graduated ratings in effect on August 19, 1968,\naward a total evaluation for two years after the date of complete arrest or inactivity established under\n38 CFR 3.375(a)\nas set forth under the general rating formula following\n38 CFR 4.97, DC 6724\nof the rating schedule\nreduce the evaluation to 50 percent for four years, and\nreduce the evaluation to 30 percent for another five years, and\nafter the expiration of the 11-year period\ncontinue the 30-percent evaluation if far advanced active lesions exist\nassign a 20-percent evaluation if there are moderately advanced lesions with continued disability, or\nassign a 0-percent evaluation if the first two criteria do not apply.\nV.iii.4.B.2.b\n.\nProcessing Ratings in Effect After August 19, 1968\nIf SC for pulmonary tuberculosis is established\nafter\nAugust 19, 1968,\ncontinue the 100-percent evaluation for one year after the date of inactivity established under\n38 CFR 3.375(a)\n, and\nthereafter apply the general rating formula for residuals in the rating schedule\nunder\n38 CFR 4.97, DC 6731\n.\nV.iii.4.B.2.c\n.\nRequesting Examinations During the Graduated Rating Period\nDo\nnot\nrequest an examination for rating purposes during the period covered by the graduated ratings.\nV.iii.4.B.2.d\n.\nProcessing Notification of Failure to Follow Treatment or Submit to Examination\nMedical authorities will notify the RO of a Veteran’s failure to follow prescribed treatment or submit to examination requested for treatment purposes during the period of total disability following complete arrest of the tuberculosis.\nAfter the notification is received, follow the due process procedures of\n38 CFR 3.655\nand furnish the Veteran a notice of proposed adverse action.  Upon expiration of the due process period\nreduce the 100-percent evaluation to 50 percent by rating action, and\nadjust the Veteran’s award as of the date of the last payment or the date indicated in the notice of proposed adverse action, whichever is later.\nNotes\n:\nThe reduction of the 100-percent evaluation upon failure to submit to examination or follow prescribed treatment is applicable\nonly\nwhen the tuberculosis has reached a stage of complete arrest or inactivity.\nIf the Veteran complies with the request for examination during the original two-year time frame for the 100-percent graduated rating, restore the 100-percent rating effective the date of reduction.\nV.iii.4.B.2.e\n.\nProcessing Cases of Irregular Discharge\nDo not suspend or discontinue payments merely because a Veteran with active tuberculosis receives an irregular discharge.  An irregular discharge is received for disciplinary reasons, the refusal to accept or follow treatment, the refusal to accept transfer, or failure to return from an authorized absence.\nIn the case of irregular discharge,\ncontinue the 100-percent evaluation based on activity, and\nrequest an examination six months from the date of irregular discharge.\nIf the Veteran fails to report for this examination, consider the tuberculosis to be completely arrested from the date of failure to report for examination.  Apply the provisions of graduated ratings based upon inactivity from this date.\nNote\n:  Compensation payments are based upon the degree of disability,\nnot\non the basis of a Veteran’s willingness to accept treatment.\n3\n.\nExhibit:  Examples of Ratings for Arrested Tuberculosis\nIntroduction\nThis exhibit contains examples of ratings for arrested tuberculosis, including\nexample 1\nexample 2\nexample 3\n, and\nexample 4\n.\nChange Date\nDecember 29, 2007\nV.iii.4.B.3.a\n.\nExample 1\nSituation\n:  A Veteran is 30-percent disabled based upon residuals of far advanced, inactive, pulmonary tuberculosis.  The rating for tuberculosis was in effect on August 19, 1968.  The tuberculosis became active on September 10, 2002.\nResult\n:  Based upon the reactivation of pulmonary tuberculosis, reinstate the 100-percent evaluation for active tuberculosis and maintain control to ascertain the date of inactivity.\nCoded Conclusion\n1. SC (KC PRES)\n6701\nTuberculosis, pulmonary, chronic, far advanced, active\n30% from 08/01/1964\n100% from 09/10/2002\nV.iii.4.B.3.b\n.\nExample 2\nSituation\n:  Same facts as in Example 1.  Examination reveals tuberculosis was inactive as of May 10, 2003.\nResult\n:  Continue the 100-percent evaluation for two years after the date of inactivity, followed by graduated reduction to 50 percent thereafter for four years.  Reduce to 30 percent from May 10, 2009, and thereafter based on far advanced lesions.\nCoded Conclusion\n1. SC (KC PRES)\n6701\nTuberculosis, pulmonary, chronic, far advanced, active\n30% from 08/01/1964\n100% from 09/10/2002\nV.iii.4.B.3.c\n.\nExample 3\nSituation\n:  Same facts as in Example 2.  Medical authorities provide notification of the Veteran’s failure to submit to examination for treatment purposes.  The notice of proposed adverse action advised that payments would be reduced effective June 1, 2004, but the date of last payment at the expiration of the due process period was July 1, 2004.\nResult\n:  Reduce the evaluation for pulmonary tuberculosis to 50 percent effective the date of last payment and to 30 percent four years later.\nCoded Conclusion\n1. SC (KC PRES)\n6721\nTuberculosis, pulmonary, chronic, far advanced inactive\n100% from 05/10/2003\n50% from 07/01/2004\n30% from 07/01/2008\nV.iii.4.B.3.d\n.\nExample 4\nSituation\n:  Same facts as in Example 3.  Medical authorities provide notification the Veteran has reported for examination on March 10, 2005.  The tuberculosis remains inactive.\nResult\n:  Reinstate the 100-percent evaluation and reduce the evaluation to 50 percent two years after the date of inactivity of pulmonary tuberculosis.  Reduce to 30 percent four years later.\nCoded Conclusion\n1. SC (KC PRES)\n6721\nTuberculosis, pulmonary, chronic, far advanced inactive\n100% from 05/10/2003\n50% from 05/10/2005\n30% from 05/10/2009\n<--\nPrevious Section\nNext Section\n-->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000180967\" articlename=\"M21-1, Part V, Subpart iii, Chapter 4, Section A - Respiratory Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180967/M21-1-Part-V-Subpart-iii-Chapter-4-Section-A-Respiratory-Conditions\">&lt;-- <strong>Previous Section</strong></a>  <a articleid=\"554400000014520\" articlename=\"M21-1, Part V, Subpart iii, Chapter 5 - Cardiovascular System Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014520/M21-1-Part-V-Subpart-iii-Chapter-5-Cardiovascular-System-Conditions\"><strong>Next Section </strong>--&gt;</a></span></span></p><h2 class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a></h2><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In This Section</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This section contains the following topics:</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 470px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 has the topic number and column 2 has the topic title.\"><thead><tr><th scope=\"col\" style=\"width: 86px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Topic</strong></span></span></div></th><th scope=\"col\" style=\"width: 423px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Topic Name</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1</span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><a href=\"#1\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">General Information on Tuberculosis</span></span></a></div></td></tr><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">2</span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><a href=\"#2\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Arrested Tuberculosis</span></span></a></div></td></tr><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">3</span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><a href=\"#3\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Exhibit: Examples of Ratings for Arrested Tuberculosis</span></span></a></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><p class=\"ng-scope\"> <br/> </p><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">1<a id=\"1\" name=\"1\">.</a>  General Information on Tuberculosis</span></span></h2><p class=\"ng-scope\"><br/> </p><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains general information about tuberculosis, including</span></span></p><ul><li><a href=\"#1a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">tuberculosis classification standards</span></span></a></li><li><a href=\"#1b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">considering infection caused by other mycobacteria</span></span></a></li><li><a href=\"#1c\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">diagnosing infection caused by other mycobacteria</span></span></a></li><li><a href=\"#1d\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">classifying disease caused by other mycobacteria</span></span></a></li><li><a href=\"#1e\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">considering chest x-rays under 38 CFR 3.370 and 38 CFR 3.371</span></span></a></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#1f\" target=\"_self\">referrals for x-ray interpretation under 38 CF. 3.370 and 38 CFR 3.371</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#1g\" target=\"_self\">processing claims based on tuberculin reaction</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">April 15, 2015</span></span></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.1.a<a id=\"1a\" name=\"1a\">.</a>  Tuberculosis Classification Standards</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The following classification standards were adopted by the American Lung Association under <em>The</em> <em>Diagnostic Standards and Classification of Tuberculosis in Adults and Children</em>, <em>1999:</em></span></span></p><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">An individual is classified as <em>Tuberculosis Suspect</em> until diagnostic procedures are complete.  (<strong><em>Note</em></strong>:  Do not use the classification <em>Tuberculosis Suspect </em>for more than three months.)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Disease caused by other mycobacteria is classified as <em>Other Mycobacterial Diseases</em>.  (<strong><em>Note</em></strong>:  Disease caused by other mycobacteria is indistinguishable clinically, radiologically, and histologically from mycobacterium (M.) tuberculosis.)</span></span></div></li></ul><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on the classification standards, see <a href=\"http://www.atsjournals.org/doi/full/10.1164/ajrccm.161.4.16141\" target=\"_blank\"><em>The</em> <em>Diagnostic Standards and Classification of Tuberculosis in Adults and Children</em>, <em>1999</em></a>.</span></span></p></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.1.b<a id=\"1b\" name=\"1b\">.</a>  Considering Infection Caused by Other Mycobacteria</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Other mycobacteria that may commonly be involved as pathogens are</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">M. kansasii</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">M. intracellulare, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">M. scrofulaceum.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  M. bovis is</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">rarely responsible for disease where there is effective control of tuberculosis in cattle and pasteurization of milk and milk products, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">indistinguishable from M. tuberculosis except by culture. </span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.1.c<a id=\"1c\" name=\"1c\">.</a>  Diagnosing Infection Caused by Other Mycobacteria</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">A definitive diagnosis for infection caused by other mycobacteria requires</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">evidence of disease (such as an infiltrate visible on a chest x-ray)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">no other cause established by careful clinical and laboratory studies, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">either</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">appearance of the same strain of mycobacteria repeatedly, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">isolation of the mycobacteria from a closed lesion from which the specimen has been collected and handled under sterile conditions.</span></span></div></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Diagnosis of other mycobacterial infection by skin test is not possible.  The current antigens for mycobacteria other than M. tuberculosis have high cross-reactivity and low specificity.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.1.d<a id=\"1d\" name=\"1d\">.</a>  Classifying Disease Caused by Other Mycobacteria</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">With certain modifications, the classification for tuberculosis is adaptable for classifying other mycobacterial diseases.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When classifying mycobacterial diseases, do <em>not</em> use the following three categories used for tuberculosis</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">“<em>no exposure, not infected</em>”</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">“<em>exposure, no evidence of infection</em>,” or</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">“<em>infection, without disease</em>.”</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.1.e<a id=\"1e\" name=\"1e\">.</a>  Considering Chest X-Rays Under 38 CFR 3.370 and 38 CFR 3.371</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If active pulmonary tuberculosis is claimed to be service-connected (SC) and entitlement is not established by other evidence, then consider the x-ray evidence in accordance with <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&amp;mc=true&amp;node=se38.1.3_1370&amp;rgn=div8\" target=\"_blank\">38 CFR 3.370</a> and <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&amp;mc=true&amp;node=se38.1.3_1371&amp;rgn=div8\" target=\"_blank\">38 CFR 3.371</a>.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Reports of x-ray interpretations <em>must</em> be adequate for rating purposes.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Use the table below to determine which x-ray films are required to prove service connection (SC).</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 481px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 provides the type of service connection to be proved and column 2 provides what films are required. \" width=\"481\"><thead><tr><th scope=\"col\" style=\"width: 258px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>To prove ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Films required are ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">direct SC</span></span></div></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">all service films.</span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">presumptive SC</span></span></div></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">discharge film (or a service film used for this) and an adequate number of post-service films.</span></span></div></td></tr></tbody></table></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.1.f<a id=\"1f\" name=\"1f\">.</a>  Referrals for X-Ray Interpretation Under 38 CFR 3.370 and 38 CFR 3.371</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Only designees of the Under Secretary for Health are authorized to interpret x-ray films under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&amp;mc=true&amp;node=se38.1.3_1370&amp;rgn=div8\" target=\"_blank\">38 CFR 3.370</a> and <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&amp;mc=true&amp;node=se38.1.3_1371&amp;rgn=div8\" target=\"_blank\">38 CFR 3.371</a>.  Refer requests for interpretations to the Department of Veterans Affairs (VA) medical facility for the local regional office (RO).</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  If the local VA medical facility is not authorized to make such interpretations, the Director will keep the RO informed of the current location of the designated interpreter for the RO area.  In such a case, refer requests directly to the clinic, center, or hospital.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.1.g<a id=\"1g\" name=\"1g\">.</a>  Processing Claims Based on Tuberculin Reaction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on claims based on positive tuberculin reaction, see <a articleid=\"554400000177450\" articlename=\"M21-1, Part VIII, Subpart iii, Chapter 2, Section A - Developing Claims for Service Connection (SC) for Positive Tuberculin Reactions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177450/M21-1-Part-VIII-Subpart-iii-Chapter-2-Section-A-Developing-Claims-for-Service-Connection-SC-for-Positive-Tuberculin-Reactions\">M21-1, Part VIII, Subpart iii, 2.A.1</a>.</span></span></p></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><p class=\"ng-scope\"> <br/> </p><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">2<a id=\"2\" name=\"2\">.</a>  Arrested Tuberculosis</span></span></h2><p class=\"ng-scope\"> <br/> </p><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information about arrested tuberculosis, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">processing </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2a\" target=\"_self\">graduated ratings in effect on August 19, 1968</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2b\" target=\"_self\">ratings in effect after August 19, 1968</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2c\" target=\"_self\">requesting examinations during the graduated rating period</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">processing </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2d\" target=\"_self\">notification of failure to follow treatment or submit to examination</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2e\" target=\"_self\">cases of irregular discharge</a>.</span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">August 3, 2011</span></span></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.2.a<a id=\"2a\" name=\"2a\">.</a>  Processing Graduated Ratings in Effect on August 19, 1968</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">For graduated ratings in effect on August 19, 1968,</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">award a total evaluation for two years after the date of complete arrest or inactivity established under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&amp;mc=true&amp;node=se38.1.3_1375&amp;rgn=div8\" target=\"_blank\">38 CFR 3.375(a)</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">as set forth under the general rating formula following <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=fba5f58206272739e8530dca72f7e5de&amp;mc=true&amp;node=se38.1.4_197&amp;rgn=div8\">38 CFR 4.97, DC 6724</a> of the rating schedule</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">reduce the evaluation to 50 percent for four years, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">reduce the evaluation to 30 percent for another five years, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">after the expiration of the 11-year period</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">continue the 30-percent evaluation if far advanced active lesions exist</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assign a 20-percent evaluation if there are moderately advanced lesions with continued disability, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assign a 0-percent evaluation if the first two criteria do not apply.</span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.2.b<a id=\"2b\" name=\"2b\">.</a>  Processing Ratings in Effect After August 19, 1968</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">If SC for pulmonary tuberculosis is established <em>after</em> August 19, 1968,</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">continue the 100-percent evaluation for one year after the date of inactivity established under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&amp;mc=true&amp;node=se38.1.3_1375&amp;rgn=div8\" target=\"_blank\">38 CFR 3.375(a)</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">thereafter apply the general rating formula for residuals in the rating schedule <span style=\"font-family: arial, helvetica, sans-serif\">under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=fba5f58206272739e8530dca72f7e5de&amp;mc=true&amp;node=se38.1.4_197&amp;rgn=div8\">38 CFR 4.97, DC 6731</a>.</span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.2.c<a id=\"2c\" name=\"2c\">.</a>  Requesting Examinations During the Graduated Rating Period</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Do <em>not</em> request an examination for rating purposes during the period covered by the graduated ratings.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.2.d<a id=\"2d\" name=\"2d\">.</a>  Processing Notification of Failure to Follow Treatment or Submit to Examination</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Medical authorities will notify the RO of a Veteran’s failure to follow prescribed treatment or submit to examination requested for treatment purposes during the period of total disability following complete arrest of the tuberculosis.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">After the notification is received, follow the due process procedures of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&amp;mc=true&amp;node=se38.1.3_1655&amp;rgn=div8\" target=\"_blank\">38 CFR 3.655</a> and furnish the Veteran a notice of proposed adverse action.  Upon expiration of the due process period</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">reduce the 100-percent evaluation to 50 percent by rating action, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">adjust the Veteran’s award as of the date of the last payment or the date indicated in the notice of proposed adverse action, whichever is later.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Notes</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The reduction of the 100-percent evaluation upon failure to submit to examination or follow prescribed treatment is applicable <em>only</em> when the tuberculosis has reached a stage of complete arrest or inactivity.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">If the Veteran complies with the request for examination during the original two-year time frame for the 100-percent graduated rating, restore the 100-percent rating effective the date of reduction.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.2.e<a id=\"2e\" name=\"2e\">.</a>  Processing Cases of Irregular Discharge</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Do not suspend or discontinue payments merely because a Veteran with active tuberculosis receives an irregular discharge.  An irregular discharge is received for disciplinary reasons, the refusal to accept or follow treatment, the refusal to accept transfer, or failure to return from an authorized absence.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In the case of irregular discharge,</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">continue the 100-percent evaluation based on activity, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">request an examination six months from the date of irregular discharge.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">If the Veteran fails to report for this examination, consider the tuberculosis to be completely arrested from the date of failure to report for examination.  Apply the provisions of graduated ratings based upon inactivity from this date.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Compensation payments are based upon the degree of disability, <em>not</em> on the basis of a Veteran’s willingness to accept treatment. </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div class=\"ng-scope\" style=\"margin-left: 1.2in\"></div><h2 class=\"ng-scope\"> <span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">3<a id=\"3\" name=\"3\">.</a>  Exhibit:  Examples of Ratings for Arrested Tuberculosis</span></span></h2><p class=\"ng-scope\"><br/> </p><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This exhibit contains examples of ratings for arrested tuberculosis, including</span></span></div><ul><li><div><a href=\"#3a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">example 1</span></span></a></div></li><li><div><a href=\"#3b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">example 2</span></span></a></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#3c\" target=\"_self\">example 3</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#3d\" target=\"_self\">example 4</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">December 29, 2007</span></span></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.3.a<a id=\"3a\" name=\"3a\">.</a>  Example 1</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  A Veteran is 30-percent disabled based upon residuals of far advanced, inactive, pulmonary tuberculosis.  The rating for tuberculosis was in effect on August 19, 1968.  The tuberculosis became active on September 10, 2002. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Based upon the reactivation of pulmonary tuberculosis, reinstate the 100-percent evaluation for active tuberculosis and maintain control to ascertain the date of inactivity.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">  </span></span><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"height: 0px; border-spacing: 1px; border-collapse: revert;\" summary=\"Sample coded conclusion.\" width=\"507\"><thead><tr><th scope=\"col\" style=\"width: 319px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Coded Conclusion</em></strong></span></span></div></th><th scope=\"col\" style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div></th></tr></thead><tbody><tr><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1. SC (KC PRES)</span></span></div></td><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div></td></tr><tr><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">6701</span></span></div></td><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Tuberculosis, pulmonary, chronic, far advanced, active</span></span></div></td></tr><tr><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">30% from 08/01/1964</span></span></div></td><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div></td></tr><tr><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">100% from 09/10/2002</span></span></div></td><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div></td></tr></tbody></table></div><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.3.b<a id=\"3b\" name=\"3b\">.</a>  Example 2</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as in Example 1.  Examination reveals tuberculosis was inactive as of May 10, 2003.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Continue the 100-percent evaluation for two years after the date of inactivity, followed by graduated reduction to 50 percent thereafter for four years.  Reduce to 30 percent from May 10, 2009, and thereafter based on far advanced lesions.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">  </span></span><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"height: 0px; border-spacing: 1px; border-collapse: revert;\" summary=\"Sample coded conclusion.\" width=\"507\"><thead><tr><th scope=\"col\" style=\"width: 319px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><span style=\"font-family: arial, helvetica, sans-serif\"><em>Coded Conclusion</em></span></strong></span></span></div></th><th scope=\"col\" style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\">1. SC (KC PRES)</span></span></span></div></td><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></div></td></tr><tr><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\">6701</span></span></span></div></td><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\">Tuberculosis, pulmonary, chronic, far advanced, active</span></span></span></div></td></tr><tr><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\">30% from 08/01/1964</span></span></span></div></td><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></div></td></tr><tr><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\">100% from 09/10/2002</span></span></span></div></td><td style=\"width: 319px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></div></td></tr></tbody></table></div><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.3.c<a id=\"3c\" name=\"3c\">.</a>  Example 3</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as in Example 2.  Medical authorities provide notification of the Veteran’s failure to submit to examination for treatment purposes.  The notice of proposed adverse action advised that payments would be reduced effective June 1, 2004, but the date of last payment at the expiration of the due process period was July 1, 2004.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Reduce the evaluation for pulmonary tuberculosis to 50 percent effective the date of last payment and to 30 percent four years later. </span></span></div><div> <table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"Sample coded conclusion\" width=\"507\"><thead><tr><th scope=\"col\" style=\"width: 253px; padding: 1px;\"><div style=\"text-align: left\"><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Coded Conclusion</em></span></span></strong></div></th><th scope=\"col\" style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></th></tr></thead><tbody><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1. SC (KC PRES)</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">6721</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Tuberculosis, pulmonary, chronic, far advanced inactive</span></span></div></td></tr><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">100% from 05/10/2003</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">50% from 07/01/2004</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">30% from 07/01/2008</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr></tbody></table></div><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.4.B.3.d<a id=\"3d\" name=\"3d\">.</a>  Example 4</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as in Example 3.  Medical authorities provide notification the Veteran has reported for examination on March 10, 2005.  The tuberculosis remains inactive.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Reinstate the 100-percent evaluation and reduce the evaluation to 50 percent two years after the date of inactivity of pulmonary tuberculosis.  Reduce to 30 percent four years later.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"Sample coded conclusion\" width=\"507\"><thead><tr><th scope=\"col\" style=\"width: 253px; padding: 1px;\"><div align=\"left\"><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Coded Conclusion</em></span></span></strong></div></th><th scope=\"col\" style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></th></tr></thead><tbody><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1. SC (KC PRES)</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">6721</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Tuberculosis, pulmonary, chronic, far advanced inactive</span></span></div></td></tr><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">100% from 05/10/2003</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">50% from 05/10/2005</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr><tr><td style=\"width: 253px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">30% from 05/10/2009</span></span></div></td><td style=\"width: 253px; padding: 1px;\"><p></p></td></tr></tbody></table><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">  </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><div class=\"ng-scope\"></div><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000180967\" articlename=\"M21-1, Part V, Subpart iii, Chapter 4, Section A - Respiratory Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180967/M21-1-Part-V-Subpart-iii-Chapter-4-Section-A-Respiratory-Conditions\">&lt;-- <strong>Previous Section</strong></a>  <a articleid=\"554400000014520\" articlename=\"M21-1, Part V, Subpart iii, Chapter 5 - Cardiovascular System Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014520/M21-1-Part-V-Subpart-iii-Chapter-5-Cardiovascular-System-Conditions\"><strong>Next Section </strong>--&gt;</a></span></span></p><p class=\"ng-scope\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#top\" target=\"_self\"><span style=\"font-size: 11px\">To Top</span></a></span></p><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://www.atsjournals.org/doi/full/10.1164/ajrccm.161.4.16141",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&mc=true&node=se38.1.3_1370&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&mc=true&node=se38.1.3_1371&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&mc=true&node=se38.1.3_1375&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=75e91c496dce5ed5644ffe9c98fc27aa&mc=true&node=se38.1.3_1655&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=fba5f58206272739e8530dca72f7e5de&mc=true&node=se38.1.4_197&rgn=div8"
  ],
  "scraped_at": "2025-06-16T22:44:39.534181",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014520/M21-1-Part-V-Subpart-iii-Chapter-5-Cardiovascular-System-Conditions"
}